消息
×
loading..
KMS

浏览/检索结果: 共4条,第1-4条 帮助

  只显示已认领条目
已选(0)清除 条数/页:   排序方式:
Design, synthesis, and structure-activity relationship studies of triazolo-pyrimidine derivatives as WRN inhibitors for the treatment of MSI tumors 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 卷号: 282
作者:  Qibang Sui;  Yuanyang Zhou;  Manjia Li;  Dan Wang;  Rongrong Cui
Adobe PDF(7302Kb)  |  收藏  |  浏览/下载:247/14  |  提交时间:2024/11/27
Mutation in CDC42 Gene Set as a Response Biomarker for Immune Checkpoint Inhibitor Therapy 期刊论文
CANCER MEDICINE, 2025, 卷号: 14, 期号: 1
作者:  Wang, Kun;  Zhang, Yingying;  Su, Zhaoming;  Wang, Bei;  Zhou, Yuanyang
Adobe PDF(6595Kb)  |  收藏  |  浏览/下载:118/1  |  提交时间:2025/01/20
PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest 期刊论文
NATURE COMMUNICATIONS, 2022, 卷号: 13, 期号: 1
作者:  Yuan, Yangyang;  Wang, Chenwei;  Zhuang, Xuran;  Lin, Shaofeng;  Luo, Miaomiao
Adobe PDF(4095Kb)  |  收藏  |  浏览/下载:530/125  |  提交时间:2022/09/28
Discovery and Development of a Series of Pyrazolo[3,4-d]pyridazinone Compounds as the Novel Covalent Fibroblast Growth Factor Receptor Inhibitors by the Rational Drug Design 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 卷号: 62, 期号: 16, 页码: 7473-7488
作者:  Wang, Yulan;  Dai, Yang;  Wu, Xiaowei;  Li, Fei;  Liu, Bo
Adobe PDF(3590Kb)  |  收藏  |  浏览/下载:635/14  |  提交时间:2019/09/10
  • 首页
  • 上一页
  • 1
  • 下一页
  • 末页